U.S. Physical Therapy, Inc. (USPH)
- Previous Close
84.63 - Open
84.00 - Bid --
- Ask --
- Day's Range
82.50 - 83.98 - 52 Week Range
78.08 - 113.63 - Volume
976 - Avg. Volume
107,314 - Market Cap (intraday)
1.251B - Beta (5Y Monthly) 1.39
- PE Ratio (TTM)
83.83 - EPS (TTM)
0.99 - Earnings Date Nov 5, 2024 - Nov 11, 2024
- Forward Dividend & Yield 1.76 (2.12%)
- Ex-Dividend Date Aug 23, 2024
- 1y Target Est
113.38
U.S. Physical Therapy, Inc. operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. U.S. Physical Therapy, Inc. was founded in 1990 and is based in Houston, Texas.
www.usph.com3,899
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: USPH
View MorePerformance Overview: USPH
Trailing total returns as of 10/2/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: USPH
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: USPH
View MoreValuation Measures
Market Cap
1.25B
Enterprise Value
1.40B
Trailing P/E
83.83
Forward P/E
29.15
PEG Ratio (5yr expected)
2.91
Price/Sales (ttm)
1.99
Price/Book (mrq)
2.58
Enterprise Value/Revenue
2.23
Enterprise Value/EBITDA
19.91
Financial Highlights
Profitability and Income Statement
Profit Margin
4.10%
Return on Assets (ttm)
4.11%
Return on Equity (ttm)
5.17%
Revenue (ttm)
621.23M
Net Income Avi to Common (ttm)
15.88M
Diluted EPS (ttm)
0.99
Balance Sheet and Cash Flow
Total Cash (mrq)
115.86M
Total Debt/Equity (mrq)
38.65%
Levered Free Cash Flow (ttm)
59.1M